Navigation Links
PAREXEL Expands Alliance Network to Support Early Phase Patient Studies, Establishes Collaboration With University Hospitals Bristol NHS Foundation Trust
Date:1/23/2012

d one of the largest acute NHS Trusts in the country. It employs over 7,900 people, and delivers over 100 different clinical services from a group of nine hospitals in the heart of the city.

With extensive, relevant experience and in-depth expertise, PAREXEL assists clients with ever more complex early-phase trial design and execution from First-in-Human (FIH) through Proof-of-Concept. The Company's hospital-based units in the U.S., Europe, and South Africa, as well as a network of alliance sites, provide clients with excellent patient access specific to key therapeutic areas for early phase development.  For more information about PAREXEL's early phase development capabilities visit: http://www.PAREXEL.com/services-and-capabilities/early-phase.

About PAREXEL InternationalPAREXEL International Corporation is a leading global bio/pharmaceutical services organization, providing a broad range of knowledge-based contract research, consulting, and medical communications services to the worldwide pharmaceutical, biotechnology and medical device industries. Committed to providing solutions that expedite time-to-market and peak-market penetration, PAREXEL has developed significant expertise across the development and commercialization continuum, from drug development and regulatory consulting to clinical pharmacology, clinical trials management, medical education and reimbursement.  Perceptive Informatics, Inc., a subsidiary of PAREXEL, provides advanced technology solutions, including medical imaging, to facilitate the clinical development process.  Headquartered near Boston, Massachusetts, PAREXEL operates in 67 locations throughout 52 countries around the world, and has approximately 10,850 employees. For more information about PAREXEL International visit www.PAREXEL.com.

This release contains "forward-looking" statements
'/>"/>

SOURCE PAREXEL International Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. PAREXEL Announces Date of Second Quarter Fiscal Year 2012 Earnings Release and Conference Call
2. PAREXEL Strengthens Late Phase and Observational Research Capabilities With Expert Team to Help Biopharma Meet Commercialization Goals
3. PAREXEL Advances Early Phase CNS Research Capabilities With Leading Medical Imaging Technology
4. UCB and PAREXEL Sign Strategic Partnership Agreement
5. PAREXEL International to Present at Lazard Capital Markets Healthcare Conference and Citi Small/Mid Cap Conference
6. PAREXEL Commercialization Experts to Present Best-Practice Approaches for Demonstrating Product Value at ISPOR Annual European Congress
7. PAREXEL Reports First Quarter Fiscal Year 2012 Financial Results
8. PAREXEL Expands Commercialization Capabilities With Dedicated Team to Help Biopharma Companies Demonstrate Product Value
9. New PAREXEL Podcast Series to Deliver Clinical Development and Commercialization Thought Leadership
10. PAREXEL and National University of Singapore Establish Program in Singapore to Meet Increasing Demand in Asia for Clinical Research Talent
11. PAREXEL Announces Date of First Quarter Fiscal Year 2012 Earnings Release and Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... , March 27, 2015 Concord ... "Company") (NYSE: CCM ), a leading specialty ... largest network of radiotherapy and diagnostic imaging centers ... the signing of a purchase agreement under which ... owned subsidiary of the Company, agreed to acquire ...
(Date:3/26/2015)... /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX:PVTTF; CSE:PVO), ("Pivotal" or the ... Omega-3 therapies for cardiovascular disease and overall health, announced ... shares of the Corporation (the "Common Shares"). The Common ... December 5 th , 2014 to March 4 th ... due on or before April 1, 2015. Interest on ...
(Date:3/26/2015)... BOTHELL, Wash. and VANCOUVER, British Columbia, March 26, ... ) today provided a summary of clinical developments ... financial results. Clinical Developments and ... December 2014, OncoGenex and Teva agreed to negotiate ... rights to OncoGenex. Negotiations of the final termination ...
Breaking Medicine Technology:Concord Medical Announces Acquisition of Fortis Surgical Hospital in Singapore 2Concord Medical Announces Acquisition of Fortis Surgical Hospital in Singapore 3Pivotal Therapeutics announces payment of interest on outstanding convertible notes 2OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 2OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 3OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 4OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 5OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 6OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 7OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 8
... today released a letter from its President Mario H. Lopez, ... dispute. At a critical time in our nation,s ... in danger of having health care choices severely affected by ... The text of the letter follows: ...
... KNSY ) today announced that it has agreed ... an attempt to resolve disputes over royalty payments to Kensey ... as other related claims. Kensey Nash has repeatedly advised St. ... should since 2007 have been paid, at a rate of ...
Cached Medicine Technology:Kensey Nash to Enter Into Mediation with St. Jude Medical over Angio-Seal Contract Disputes 2Kensey Nash to Enter Into Mediation with St. Jude Medical over Angio-Seal Contract Disputes 3Kensey Nash to Enter Into Mediation with St. Jude Medical over Angio-Seal Contract Disputes 4
(Date:3/27/2015)... 2015 Endure Yoga is launching WOD ... athletes. This new program matches yoga poses with functional ... cool down. This program utilizes yoga to improve recovery, ... focus. , Karen Lefurgy, competitive athlete at ... before I started Crossfit® training, but quickly, due to ...
(Date:3/27/2015)... 2015 GenSight, the leading Enterprise Portfolio ... Fitzgerald, a former technology and financial executive to serve ... Chief Financial Officer. , Mr Fitzgerald was most recently ... backed by Amazon founder and CEO Jeff Bezos, Google ... to EverFi, he was a Senior Vice President at ...
(Date:3/27/2015)... Grants Pass, OR (PRWEB) March 27, 2015 ... record breaking winter blizzards in Boston and the United ... climate change patterns. Earth warming global atmosphere is creating ... DeWayne Cecil, PhD, historical climatologist and former NASA researcher, ... radio show. The result is not only a warmer ...
(Date:3/27/2015)... CT (PRWEB) March 27, 2015 Trail mix ... after a workout, on weekend hikes and during the game! ... benefits. Aurora Natural is proud to introduce a new line ... taste buds. Deliciously rich and flavorful selections packed with nutritious, ... seeds, dried fruit and grains that add protein and fiber ...
(Date:3/27/2015)... March 27, 2015 The 2015 ... is a professional and in-depth study on the ... with a focus on the Chinese situation. ... the industry including definitions, classifications, applications and industry ... for both the international and Chinese domestic situations ...
Breaking Medicine News(10 mins):Health News:Endure Yoga Introduces WOD Recovery Yoga 2Health News:GenSight Appoints Former Technology Executive as Chief Operating Officer 2Health News:California Drought, Boston Blizzards Both Attributed to Global Climate Change Reports Climatologist to Fresh Water Advocate 2Health News:California Drought, Boston Blizzards Both Attributed to Global Climate Change Reports Climatologist to Fresh Water Advocate 3Health News:Aurora Product, Inc. Introduces New Line of Specialty Trail Mixes 2Health News:Glutathione Industry International and China Market Analysis Report 2015-2020 2Health News:Glutathione Industry International and China Market Analysis Report 2015-2020 3
... David and Lucile Packard Foundation,announce new projects supporting ... WASHINGTON, Feb. 6 The Robert Wood Johnson,Foundation ... (Packard),each announced grant projects today that will considerably ... of the nation,s most pressing health care,problems are ...
... (OTC Bulletin Board: GXYF), a leading developer and marketer ... food,products, today announced that it will host an investor ... for the 2008 fiscal year at,11:00 a.m. EST on ... its,operating results before the market opens the same day., ...
... seek restatement of Beth Israel Deaconess,Medical Center audit, ... director Stephen Chubb should apply the same Sarbanes-Oxley,standards ... traded,companies to his role on the board of ... Center (BIDMC), according to labor group 1199,SEIU United ...
... Register Now - Space is Limited, BOSTON, Feb. ... an innovative and timely,course that will be presented under ... The course, which will be held,at the Omni Parker ... is a,follow-up to a successful 2006 event that attracted ...
... in a large, multi-institutional study comparing the accuracy of ... the characterization of lung nodules found that PET was ... nodule was malignant. , CT and PET have been ... benign or malignant, said James W. Fletcher, professor of ...
... Quarter 2008 Sees 52 Percent Increase in Sales from Same ... ... Greenway Medical Technologies,Inc., a leading provider of integrated electronic health records ... its second quarter of fiscal 2008, ending,December 31, 2007, were up ...
Cached Medicine News:Health News:Foundations to Strengthen State Health Care Reform Advocacy 2Health News:Foundations to Strengthen State Health Care Reform Advocacy 3Health News:Foundations to Strengthen State Health Care Reform Advocacy 4Health News:Galaxy Nutritional Foods Announces Third Quarter FY2008 Earnings Conference Call for Friday, February 8, 2008 2Health News:Charles River Laboratories International Board Member Should Use Sarbanes-Oxley Disclosure Rules in Non-Profit Role, Asserts 1199 SEIU 2Health News:Innovative eHealth Course to Take Place March 28-30 in Boston, Massachusetts 2Health News:PET outperforms CT in characterization of lung nodules 2Health News:Greenway Medical Technologies Continues Record Setting Growth 2Health News:Greenway Medical Technologies Continues Record Setting Growth 3Health News:Greenway Medical Technologies Continues Record Setting Growth 4
... / MVR knife. 1.1 mm (19G) with a ... (19G) Cannula (5/bx, 1 bx/ca). State-of-the-art manufacturing and ... and precise. Sure grip handles have a ridge ... a fluid tight incision for self-sealing wounds. Gauge ...
For use in cleaning soft contact lenses. Sensitive Eyes daily cleaner loosens and removes accumulations of film, deposits, and debris from soft contact lenses. Use with heat, chemical, and hydrogen p...
Complete Blink-N-Clean lens drops cleans and clears lenses in a blink. It is a unique blend of gentle to the eye ingredients that conveniently cleans, clears and keeps lenses feeling comfortable thro...
... Renu Multiplus preservative free ... and moisturize your eyes while ... The gentle preservative free formula ... may be sensitive to preservatives ...
Medicine Products: